Breakfast Activity/Non-CE Accredited Satellite Symposium: Adverse event management and patient adherence in gastric/GEJ cancer treatment: The vital role of advanced practitioners in supporting treatment with Claudin18.2 targeting therapy with emphasis on zolbetuximab Astellas Pharma Inc
Sunday, November 17, 2024
8:30 AM – 9:30 AM CT
Location: Dallas 5
Leslie Swanson, AGPCNP-BC, AOCNP Michael Robles, PharmD, BCOP University of Washington Medicine/Fred Hutchinson Cancer Center